NCT05494333

Brief Summary

The aims of this study are:

  1. 1.To determine the correlation between pulmonary functions and physical fitness in children with β-thalassemia.
  2. 2.To differentiate between different types of B-thalassemia in both pulmonary functions and physical fitness

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 30, 2022

Completed
2 days until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 9, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 9, 2022

Status Verified

August 1, 2022

Enrollment Period

2 months

First QC Date

July 30, 2022

Last Update Submit

August 8, 2022

Conditions

Outcome Measures

Primary Outcomes (3)

  • assessment of pulmonary functions by spirometer

    measurements difference in vital capacity and minute ventilation

    baseline - one hour for each participant

  • physical fitness

    functional capacity by 6 minute walk test

    baseline - one hour for each participant

  • cardiorespiratory fitness

    measure by 3 minutes step test to monitor recovery of heart rate after stress test

    baseline - one hour for each participant

Study Arms (1)

2

NO INTERVENTION

Other: no intervention

Interventions

NO intervention

2

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

Cohort study: cross-sectional design A) Subjects: Sample size estimation will be carried out to determine the recruited number of children selected randomly. Each participant's caregiver will sign a consent form authorizing the participation of their children in this study

You may qualify if:

  • age range from 6 to 12 years
  • children with β-thalassemia major and intermediate of both sex and control healthy children of both sex
  • They can follow instruction

You may not qualify if:

  • Defined Cardiovascular or respiratory disorders.
  • Renal failure
  • Visual or hearing impairment, Mentally retarded children
  • Myocardial infarction within the last month
  • Unstable angina, Recent thoraco-abdominal surgery
  • Thoracic or abdominal aneurysm or Current pneumothorax

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Esraa Elsayed

Cairo, Egypt

RECRUITING

Study Officials

  • esraa elsayed

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecture

Study Record Dates

First Submitted

July 30, 2022

First Posted

August 9, 2022

Study Start

August 1, 2022

Primary Completion

October 1, 2022

Study Completion

December 1, 2022

Last Updated

August 9, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations